Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · December 23, 2021

Erenumab Shows Greater Efficacy and Tolerability Than Topiramate for Migraine Prevention

Cephalalgia: An International Journal of Headache

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cephalalgia: An International Journal of Headache
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial
Cephalalgia 2021 Nov 07;[EPub Ahead of Print], U Reuter, M Ehrlich, A Gendolla, A Heinze, J Klatt, S Wen, P Hours-Zesiger, J Nickisch, C Sieder, C Hentschke, M Maier-Peuschel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading